Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant‐treated rectal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2024 at "Histopathology"
DOI: 10.1111/his.15192
Abstract: Tumour budding (TB) is a marker of tumour aggressiveness which, when measured in rectal cancer resection specimens, predicts worse outcomes and response to neoadjuvant therapy. We investigated the utility of TB assessment in the setting… read more here.
Keywords: budding prognostic; biomarker biopsies; prognostic biomarker; resections neoadjuvant ... See more keywords